| Accession Number | 0002113721-26-000018 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 29, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CEO, Diagnostics | Class A Common Stock | โ | Sep 25, 2026 | Sale | 10,281 | $85.00 | $873,885.00 | 76,740 | Direct | โ | View Details |